002166 莱茵生物
已收盘 07-19 15:00:00
资讯
新帖
简况
莱茵生物新提交3件商标注册申请
证券之星 · 07-12
莱茵生物新提交3件商标注册申请
莱茵生物:7月10日高管姚新德减持股份合计20.86万股
证券之星 · 07-11
莱茵生物:7月10日高管姚新德减持股份合计20.86万股
代糖(甜味剂)概念盘中拉升,莱茵生物涨1.66%
自选股智能写手 · 07-09
代糖(甜味剂)概念盘中拉升,莱茵生物涨1.66%
莱茵生物(002166.SZ)发预增,预计上半年净利润5429.46万元–6515.36万元 增长50%—80%
智通财经 · 07-08
莱茵生物(002166.SZ)发预增,预计上半年净利润5429.46万元–6515.36万元 增长50%—80%
莱茵生物:预计2024年1-6月归属净利润盈利5429.46万元至6515.36万元
证券之星 · 07-08
莱茵生物:预计2024年1-6月归属净利润盈利5429.46万元至6515.36万元
莱茵生物最新公告:预计上半年净利同比增长50%-80%
证券之星 · 07-08
莱茵生物最新公告:预计上半年净利同比增长50%-80%
莱茵生物:7月2日高管姚新德减持股份合计43.57万股
证券之星 · 07-03
莱茵生物:7月2日高管姚新德减持股份合计43.57万股
莱茵生物最新公告:公司董事、高管拟合计减持不超0.94%股份
证券之星 · 06-06
莱茵生物最新公告:公司董事、高管拟合计减持不超0.94%股份
莱茵生物(002166.SZ)部分董事高管拟减持不超0.94%股份
智通财经 · 06-06
莱茵生物(002166.SZ)部分董事高管拟减持不超0.94%股份
莱茵生物:鉴于美国工厂暂未大规模开展原料加工,尚不涉及大量THC存储的问题
证券之星 · 05-29
莱茵生物:鉴于美国工厂暂未大规模开展原料加工,尚不涉及大量THC存储的问题
莱茵生物(002166.SZ)2023年度拟每10股派2元 6月3日除权除息
智通财经 · 05-24
莱茵生物(002166.SZ)2023年度拟每10股派2元 6月3日除权除息
莱茵生物(002166)5月23日主力资金净卖出3584.24万元
证券之星 · 05-24
莱茵生物(002166)5月23日主力资金净卖出3584.24万元
莱茵生物(002166)5月22日主力资金净卖出5271.39万元
证券之星 · 05-23
莱茵生物(002166)5月22日主力资金净卖出5271.39万元
5月16日莱茵生物(002166)龙虎榜数据:游资国君宜昌珍珠路、上塘路上榜
证券之星 · 05-16
5月16日莱茵生物(002166)龙虎榜数据:游资国君宜昌珍珠路、上塘路上榜
5月15日莱茵生物(002166)龙虎榜数据:游资方新侠上榜
证券之星 · 05-15
5月15日莱茵生物(002166)龙虎榜数据:游资方新侠上榜
龙虎榜 | 3.22亿资金狂扫汤姆猫,佛山系、方新侠上榜!消闲派抢筹合成生物概念股
格隆汇 · 05-14
龙虎榜 | 3.22亿资金狂扫汤姆猫,佛山系、方新侠上榜!消闲派抢筹合成生物概念股
5月14日莱茵生物(002166)龙虎榜数据:游资国君宜昌珍珠路、上塘路、量化打板、方新侠上榜
证券之星 · 05-14
5月14日莱茵生物(002166)龙虎榜数据:游资国君宜昌珍珠路、上塘路、量化打板、方新侠上榜
莱茵生物(002166)5月13日主力资金净买入1.63亿元
证券之星 · 05-14
莱茵生物(002166)5月13日主力资金净买入1.63亿元
莱茵生物积极推进合成生物业务 两大产品具备量产可能
证券 · 05-12
莱茵生物积极推进合成生物业务 两大产品具备量产可能
莱茵生物(002166)5月8日主力资金净买入1.38亿元
证券之星 · 05-09
莱茵生物(002166)5月8日主力资金净买入1.38亿元
加载更多
公司概况
公司名称:
桂林莱茵生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2007-09-13
主营业务:
桂林莱茵生物科技股份有限公司主要从事天然健康产品业务,主要产品是罗汉果提取物、甜叶菊提取物、工业大麻提取物、茶叶提取物及其他保健护肤提取物。公司先后获得“植物提取物优质供应商”、“中国质量诚信企业”、“中国农业企业500强”等殊荣,2023年顺利通过“国家级专精特新小巨人企业”、“农业产业化国家重点龙头企业”等荣誉复审,作为植物提取行业绿色转型升级的示范标杆企业更是取得了“国家级绿色工厂”的荣誉称号。
发行价格:
9.89
{"stockData":{"symbol":"002166","market":"SZ","secType":"STK","nameCN":"莱茵生物","latestPrice":6.95,"timestamp":1721372601000,"preClose":6.99,"halted":0,"volume":7148067,"delay":0,"floatShares":513999999,"shares":742000000,"eps":0.1205,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.04,"latestTime":"07-19 15:00:00","open":6.96,"high":7,"low":6.92,"amount":49762600,"amplitude":0.0114,"askPrice":6.95,"askSize":383,"bidPrice":6.94,"bidSize":1216,"shortable":0,"etf":0,"ttmEps":0.1205,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":6.99,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":7.69,"lowLimit":6.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":741986825,"pbRate":1.67,"roa":"--","roe":"0.86%","epsLYR":0.11,"committee":-0.013546,"marketValue":5157000000,"floatMarketCap":3569000000,"peRate":57.676349,"changeRate":-0.0057,"turnoverRate":0.0139,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-07-22。"},"requestUrl":"/m/hq/s/002166","defaultTab":"news","newsList":[{"id":"2450273843","title":"莱茵生物新提交3件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2450273843","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450273843?lang=zh_cn&edition=full","pubTime":"2024-07-12 13:04","pubTimestamp":1720760654,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日桂林莱茵生物科技股份有限公司新提交3件商标注册申请。商标申请详情如下:今年以来桂林莱茵生物科技股份有限公司新申请注册商标13件,截止目前公司共持有注册商标398件,另有42件商标尚在注册申请中。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200023229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002166","BK0168","BK0046","BK0239","BK0174"],"gpt_icon":0},{"id":"2450357669","title":"莱茵生物:7月10日高管姚新德减持股份合计20.86万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450357669","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450357669?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:00","pubTimestamp":1720702852,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月11日市场公开信息、上市公司公告及交易所披露数据整理,莱茵生物最新董监高及相关人员股份变动情况:2024年7月10日公司董事姚新德共减持公司股份20.86万股,占公司总股本为0.0281%。莱茵生物近半年内的董监高及核心技术人员增减持详情如下:莱茵生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出333.28万,融资余额减少;融券净流出1600.0,融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100041262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0168","002166","BK0174","BK0028","BK0046"],"gpt_icon":0},{"id":"2450552910","title":"代糖(甜味剂)概念盘中拉升,莱茵生物涨1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450552910","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450552910?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:46","pubTimestamp":1720489596,"startTime":"0","endTime":"0","summary":"07月09日,代糖(甜味剂)概念盘中拉升,截至09点46分,代糖(甜味剂)概念整体指数上涨0.52%,报753.240点。从个股上来看,该概念的成分股中,莱茵生物涨1.66%,鲁信创投、三元生物、华康股份涨幅居前。从资金上来看,截止发稿,代糖(甜味剂)概念主力净流入为-687.36万,其中鲁信创投受到资金热捧,主力净流入144.63万;拉长时间线来看,该板块近20日主力资金净流入-3.41亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094636941f51aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094636941f51aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002166","BK0075","BK0168","BK0239","BK0276","600783","BK0174","BK0188","BK0046","BK0059","BK0028"],"gpt_icon":0},{"id":"2449524778","title":"莱茵生物(002166.SZ)发预增,预计上半年净利润5429.46万元–6515.36万元 增长50%—80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449524778","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449524778?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:37","pubTimestamp":1720435027,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莱茵生物 发布2024年半年度业绩预告,预计上半年归属于上市公司股东的净利润5429.46万元–6515.36万元,同比增长50%—80%。净利润方面,受益于营收增长、毛利率提升及股份支付成本减少等因素,报告期内公司利润大幅提升,预计公司半年度归属于上市公司股东的净利润将同比增长50%–80%。同时,由于公司主营业务利润的占比大幅提升,预计报告期扣除非经常性损益后的净利润较上年同期增长约1041.73%—1315.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002166"],"gpt_icon":0},{"id":"2449727741","title":"莱茵生物:预计2024年1-6月归属净利润盈利5429.46万元至6515.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449727741","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449727741?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:02","pubTimestamp":1720432939,"startTime":"0","endTime":"0","summary":"证券之星消息,莱茵生物发布业绩预告,预计2024年1-6月归属净利润盈利5429.46万元至6515.36万元。同时,由于公司主营业务桂林莱茵生物科技股份有限公司利润的占比大幅提升,预计报告期扣除非经常性损益后的净利润较上年同期增长约 1041.73%—1315.69%。莱茵生物2024年一季报显示,公司主营收入3.41亿元,同比上升35.07%;归母净利润2679.01万元,同比上升34.37%;扣非净利润3957.09万元,同比上升372.05%;负债率33.19%,财务费用345.99万元,毛利率26.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800024970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"gpt_icon":0},{"id":"2449276537","title":"莱茵生物最新公告:预计上半年净利同比增长50%-80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449276537","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449276537?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:00","pubTimestamp":1720432857,"startTime":"0","endTime":"0","summary":"莱茵生物公告,预计2024年半年度净利润5429.46万元–6515.36万元,同比增长50%–80%。受益于营收增长、毛利率提升及股份支付成本减少等因素,报告期内公司利润大幅提升。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800024699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","002166","BK0046","BK0168","BK0028","BK0239"],"gpt_icon":0},{"id":"2448100934","title":"莱茵生物:7月2日高管姚新德减持股份合计43.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448100934","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448100934?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:06","pubTimestamp":1720011981,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月3日市场公开信息、上市公司公告及交易所披露数据整理,莱茵生物最新董监高及相关人员股份变动情况:2024年7月2日公司董事姚新德共减持公司股份43.57万股,占公司总股本为0.0587%。莱茵生物近半年内的董监高及核心技术人员增减持详情如下:莱茵生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出44.17万,融资余额减少;融券净流入8000.0,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300045571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002166","BK0239","BK0168","BK0174","BK0028"],"gpt_icon":0},{"id":"2441671139","title":"莱茵生物最新公告:公司董事、高管拟合计减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2441671139","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441671139?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:41","pubTimestamp":1717677713,"startTime":"0","endTime":"0","summary":"莱茵生物公告,公司董事姚新德,董事、常务副总经理谢永富,董事、副总经理白昱,副总经理、董事会秘书罗华阳,财务总监郑辉计划在公告披露之日起15个交易日后3个月内,以集中竞价交易方式和大宗交易方式合计减持不超过0.94%股份。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060600042587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0239","002166","BK0174","BK0028","BK0046"],"gpt_icon":0},{"id":"2441719174","title":"莱茵生物(002166.SZ)部分董事高管拟减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2441719174","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441719174?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:36","pubTimestamp":1717677399,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莱茵生物(002166.SZ)发布公告,公司董事姚新德先生,董事、常务副总经理谢永富先生,董事、副总经理白昱先生,副总经理、董事会秘书罗华阳先生,财务总监郑辉女士(以下简称“上述人员”)计划在本公告披露之日起15个交易日后3个月内(2024年7月2日至2024年9月30日),以集中竞价交易方式和大宗交易方式减持其持有的部分公司股份。本次拟减持的股份合计不超过689.52万股,即不超过公司剔除回购专用证券账户后总股本的0.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0168","BK0174","BK0046","BK0028","002166","BK0239"],"gpt_icon":0},{"id":"2439542488","title":"莱茵生物:鉴于美国工厂暂未大规模开展原料加工,尚不涉及大量THC存储的问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2439542488","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439542488?lang=zh_cn&edition=full","pubTime":"2024-05-29 19:02","pubTimestamp":1716980556,"startTime":"0","endTime":"0","summary":"另外,由于印第安纳州暂未将THC合法化,该等副产物应该无法体现在财务账面。同时,目前美国联邦及各州对于THC成分的监管开放进程不一,公司将严格按照美国联邦及各州法律法规要求开展经营活动,谢谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052900036369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0046","BK0174","BK0028","BK0239","BK0168"],"gpt_icon":0},{"id":"2437031890","title":"莱茵生物(002166.SZ)2023年度拟每10股派2元 6月3日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2437031890","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437031890?lang=zh_cn&edition=full","pubTime":"2024-05-24 20:38","pubTimestamp":1716554325,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莱茵生物(002166.SZ)公告,公司2023年年度拟向全体股东每10股派发现金红利2.00元(含税),本次权益分派股权登记日为2024年5月31日;除权除息日为2024年6月3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1126062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","002166","BK0174","BK0168","BK0239","BK0046"],"gpt_icon":0},{"id":"2437740289","title":"莱茵生物(002166)5月23日主力资金净卖出3584.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437740289","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437740289?lang=zh_cn&edition=full","pubTime":"2024-05-24 09:22","pubTimestamp":1716513762,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月23日收盘,莱茵生物报收于7.93元,下跌4.23%,换手率7.99%,成交量41.04万手,成交额3.28亿元。近5日资金流向一览见下表:莱茵生物融资融券信息显示,融资方面,当日融资买入3407.69万元,融资偿还4163.57万元,融资净偿还755.88万元。莱茵生物主营业务:天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400015537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0239","002166","BK0174","BK0028","BK0046"],"gpt_icon":0},{"id":"2437227461","title":"莱茵生物(002166)5月22日主力资金净卖出5271.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437227461","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437227461?lang=zh_cn&edition=full","pubTime":"2024-05-23 09:20","pubTimestamp":1716427221,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月22日收盘,莱茵生物报收于8.28元,下跌2.47%,换手率8.97%,成交量46.05万手,成交额3.83亿元。近5日资金流向一览见下表:莱茵生物融资融券信息显示,融资方面,当日融资买入3952.79万元,融资偿还3961.21万元,融资净偿还8.42万元。莱茵生物主营业务:天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052300014354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002166","BK0046","BK0168","BK0174","BK0239"],"gpt_icon":0},{"id":"2435624144","title":"5月16日莱茵生物(002166)龙虎榜数据:游资国君宜昌珍珠路、上塘路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2435624144","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435624144?lang=zh_cn&edition=full","pubTime":"2024-05-16 17:13","pubTimestamp":1715850837,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2024年5月16日公布的交易公开信息显示,莱茵生物因日跌幅偏离值达到7%的前5只证券,日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2024年5月16日收盘,莱茵生物报收于8.36元,下跌9.82%,换手率27.14%,成交量139.4万手,成交额11.98亿元。国君宜昌珍珠路、上塘路等知名游资榜上有名。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051600027148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0174","BK0239","002166","BK0028","BK0046"],"gpt_icon":0},{"id":"2435684769","title":"5月15日莱茵生物(002166)龙虎榜数据:游资方新侠上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2435684769","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435684769?lang=zh_cn&edition=full","pubTime":"2024-05-15 17:14","pubTimestamp":1715764462,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2024年5月15日公布的交易公开信息显示,莱茵生物因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2024年5月15日收盘,莱茵生物报收于9.27元,下跌10.0%,跌停,换手率3.18%,成交量16.33万手,成交额1.51亿元。从龙虎榜公布的当日买卖数据来看,方新侠等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500030075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0174","BK0239","002166","BK0168"],"gpt_icon":0},{"id":"2435955835","title":"龙虎榜 | 3.22亿资金狂扫汤姆猫,佛山系、方新侠上榜!消闲派抢筹合成生物概念股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435955835","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435955835?lang=zh_cn&edition=full","pubTime":"2024-05-14 18:12","pubTimestamp":1715681576,"startTime":"0","endTime":"0","summary":"今日龙虎榜净买入额前三为汤姆猫、北方铜业、鲁抗医药","market":"us","thumbnail":"https://img3.gelonghui.com/94236-7454789a-fe19-43f5-8784-eef511ba5f38.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/94236-7454789a-fe19-43f5-8784-eef511ba5f38.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/734723","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0239","BK0174","BK0077","BK0046","300459","BK0217","BK0014","BK0065","600686","BK0168","BK0270","601022","BK0229","BK0199","BK0164","BK0188","BK0094","BK0010","BK0264","002166","BK0233","002455","600789","BK0131","000737","BK0028"],"gpt_icon":0},{"id":"2435567166","title":"5月14日莱茵生物(002166)龙虎榜数据:游资国君宜昌珍珠路、上塘路、量化打板、方新侠上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2435567166","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435567166?lang=zh_cn&edition=full","pubTime":"2024-05-14 17:12","pubTimestamp":1715677953,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2024年5月14日公布的交易公开信息显示,莱茵生物因日涨幅偏离值达到7%的前5只证券,日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2024年5月14日收盘,莱茵生物报收于10.3元,上涨10.04%,涨停,换手率32.68%,成交量167.8万手,成交额17.04亿元。从龙虎榜公布的当日买卖数据来看,国君宜昌珍珠路、上塘路、量化打板、方新侠等知名游资榜上有名。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400025576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0168","BK0028","BK0174","BK0046","BK0239"],"gpt_icon":0},{"id":"2435384785","title":"莱茵生物(002166)5月13日主力资金净买入1.63亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435384785","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435384785?lang=zh_cn&edition=full","pubTime":"2024-05-14 09:11","pubTimestamp":1715649091,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月13日收盘,莱茵生物报收于9.36元,上涨6.0%,换手率22.16%,成交量113.79万手,成交额10.62亿元。近5日资金流向一览见下表:莱茵生物融资融券信息显示,融资方面,当日融资买入1.21亿元,融资偿还9978.61万元,融资净买入2079.77万元。莱茵生物主营业务:天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400008467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002166","BK0046","BK0168","BK0239","BK0174"],"gpt_icon":0},{"id":"2434334946","title":"莱茵生物积极推进合成生物业务 两大产品具备量产可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2434334946","media":"证券","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434334946?lang=zh_cn&edition=full","pubTime":"2024-05-12 19:33","pubTimestamp":1715513580,"startTime":"0","endTime":"0","summary":"5月11日,莱茵生物(维权)发布的投资者关系活动记录表显示,公司已有两大产品具备量产可能:一是通过酶转化工艺生产的甜叶菊部分高价值成分,二是公司控股子公司成都赛迪科创新研发的生物多糖产品。据了解,莱茵生物于2022年正式将合成生物纳入公司战略发展方向,建立天然提取和生物合成双技术路线比翼齐飞的发展格局。浙商证券研报表示,莱茵生物合成生物技术稳步推进,有望构筑长期竞争优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-05-12/doc-inauyrax6078752.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-05-12/doc-inauyrax6078752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002166","BK0168","BK0174","BK0028","BK0046","BK0239"],"gpt_icon":0},{"id":"2434843420","title":"莱茵生物(002166)5月8日主力资金净买入1.38亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434843420","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434843420?lang=zh_cn&edition=full","pubTime":"2024-05-09 09:11","pubTimestamp":1715217062,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月8日收盘,莱茵生物报收于9.08元,上涨10.06%,涨停,换手率16.15%,成交量82.95万手,成交额7.24亿元。近5日资金流向一览见下表:莱茵生物融资融券信息显示,融资方面,当日融资买入7175.9万元,融资偿还5741.94万元,融资净买入1433.96万元。莱茵生物主营业务:天然健康产品的生产经营业务,持续专注植物功能性成分提取领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900015060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0168","002166","BK0028","BK0046","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2007-09-13","address":"广西壮族自治区桂林市临桂区人民南路19号","stockEarnings":[{"period":"1week","weight":-0.0156},{"period":"1month","weight":-0.0128},{"period":"3month","weight":0.0162},{"period":"6month","weight":-0.024},{"period":"1year","weight":-0.077},{"period":"ytd","weight":-0.0818}],"companyName":"桂林莱茵生物科技股份有限公司","boardCode":"AI0027","perCapita":"9666股","boardName":"医药制造业","registeredCapital":"74198万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 桂林莱茵生物科技股份有限公司主要从事天然健康产品业务,主要产品是罗汉果提取物、甜叶菊提取物、工业大麻提取物、茶叶提取物及其他保健护肤提取物。公司先后获得“植物提取物优质供应商”、“中国质量诚信企业”、“中国农业企业500强”等殊荣,2023年顺利通过“国家级专精特新小巨人企业”、“农业产业化国家重点龙头企业”等荣誉复审,作为植物提取行业绿色转型升级的示范标杆企业更是取得了“国家级绿色工厂”的荣誉称号。","serverTime":1721445660238,"listedPrice":9.89,"stockholders":"53122人(较上一季度增加0.22%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱茵生物,002166,莱茵生物股票,莱茵生物股票老虎,莱茵生物股票老虎国际,莱茵生物行情,莱茵生物股票行情,莱茵生物股价,莱茵生物股市,莱茵生物股票价格,莱茵生物股票交易,莱茵生物股票购买,莱茵生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}